Together with the migration enhancing effect of IGFBP2 in human leukemia cells (Figure 2H-I), our results suggest that IGFBP2 enhances the mobilization of AML cells, thus accelerating AML development. The gene discussed is IGFBP2; the disease is acute myeloid leukemia.